Press Releases
24 September 2019
PRINCETON, N.J., Sept. 24, 2019 /PRNewswire/ -- In today's world, there is no greater commodity than personal health, which is why Jeff B. Smith, former Company Group Chairman of Johnson & Johnson NA, and scientist and former Olympic coach, Sam Bock, are pairing up to launch
Read more...WOODCLIFF LAKE, N.J., Sept. 24, 2019 /PRNewswire/ -- Eisai today announced the presentation of new data and analyses via one oral proffered paper presentation, four poster discussions and seven poster presentations at the 2019 European Society for Medical Oncology (ESMO) Annual Meeting from September 27 – October
Read more...24 September 2019
WASHINGTON, Sept. 24, 2019 /PRNewswire/ -- Aflac, a committed corporate ally to families facing childhood cancer, and
Read more...24 September 2019
SEATTLE, Sept. 24, 2019 /PRNewswire/ -- A new report by RealSelf, the leading online resource to research aesthetic procedures and connect with doctors,
Read more...24 September 2019
NEW YORK, Sept. 24, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Executive Officer, will
Read more...24 September 2019
AUSTIN, Texas, Sept. 24, 2019 /PRNewswire/ -- Santé Ventures, a healthcare and life sciences investment firm specializing in early-stage companies developing innovative new medical
Read more...HARLEYSVILLE, Pa., Sept. 24, 2019 /PRNewswire/ -- Alliance Contract Pharma (ACP) announced today that the Company's new $2 million Li
Read more...24 September 2019
DOVER, Delaware, Sept. 24, 2019 /PRNewswire/ -- CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Fenestrated Pedicle Screw System used in the treatment of patients with advanced stage spinal tumors.
Read more...24 September 2019
SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients w
Read more...